• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

FriskaAi Integrates with Dexcom’s CGM Data for AI-Powered Diabetes Management

by Jasmine Pennic 08/13/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
FriskaAi Integrates with Dexcom’s CGM Data for AI-Powered Diabetes Management

What You Should Know: 

– FriskaAi, an AI-powered healthcare platform, has announced an agreement with Dexcom, Inc., a global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into its platform. 

– The collaboration will enable FriskaAi to use continuous glucose data to support physicians and patients with actionable, personalized care management programs.

Physician-Directed Platform for Chronic Disease Management

FriskaAi is a physician-directed health and wellness platform that helps providers take an evidence-based approach to preventive care for diabetes and other chronic diseases. The platform is EHR-agnostic and uses advanced AI and mobile technology to generate personalized health insights and recommendations, empowering patients to take control of their health in partnership with their clinical team.

The integration with Dexcom CGMs is a major step in this effort. Dexcom CGMs use a small, wearable sensor to continuously measure and wirelessly send glucose levels to a smart device in real-time, eliminating the need for fingerpricks. The devices also provide customizable alerts for high or low glucose levels and predictive alerts to help users stay within a healthy range.

Integration with Smart Devices and Health Apps

The FriskaAi mobile app securely integrates with Dexcom CGMs and other smart devices and health apps. The data from these devices, along with other clinical information, is continuously monitored by HIPAA-compliant, AI-powered algorithms. These algorithms alert patients when action is recommended and generate actionable reports for clinicians to use at the point of care.

Aggregated health data within the FriskaAi platform is also analyzed to help physicians identify trends and risks within their patient populations, which enables more proactive and preventive care strategies. This partnership is set to enhance chronic disease management by providing timely, personalized insights and empowering both patients and their clinical teams.

“Impacting more than 38 million Americans, diabetes has emerged as a major public health problem, and its effective management has become a foundational element of preventive medicine,” says Shaji Nair, CEO of FriskaAi. “Dexcom’s pioneering CGMs are vital tools not only for diabetes management but also for informing broader care decisions. FriskaAi is excited about the potential this integration with Dexcom presents to the physicians relying on our platform for chronic disease management and the patients seeking greater control over their health and wellness.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Continuous Glucose Monitoring (CGM), Diabetes Management

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

The AI Paradox in Healthcare: Notable CEO Shares Why Moving Too Slowly is a Greater Risk

Most-Read

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Patient Square Capital Acquires Premier in $2.6B Deal

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |